Novel Drug Candidate Prediction for Intrahepatic Cholangiocarcinoma via Hub Gene Network Analysis and Connectivity Mapping

SIMPLE SUMMARY: Only about 15% of intrahepatic cholangiocarcinoma (ICC) patients meet the criteria for resection at the time of diagnosis. For patients with advanced and/or metastatic disease, the development of novel therapeutic strategies is urgently needed. The aim of our study was to identify po...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yao, Zhang, Baoluhe, Cloyd, Jordan M., Alaimo, Laura, Xu, Gang, Du, Shunda, Mao, Yilei, Pawlik, Timothy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265136/
https://www.ncbi.nlm.nih.gov/pubmed/35805055
http://dx.doi.org/10.3390/cancers14133284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265136/
https://www.ncbi.nlm.nih.gov/pubmed/35805055
http://dx.doi.org/10.3390/cancers14133284

Ejemplares similares